As of December 2024 Avalon Pharma (Middle East Pharmaceutical) has a market cap of HK$4.91 Billion. This makes Avalon Pharma (Middle East Pharmaceutical) the world's 6327th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.